相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Phase Ib Study of Alpelisib (BYL719), a PI3K alpha-Specific Inhibitor, with Letrozole in ER+/HER2(-) Metastatic Breast Cancer
Ingrid A. Mayer et al.
CLINICAL CANCER RESEARCH (2017)
SANDPIPER: Phase III study of the PI3-kinase (PI3K) inhibitor taselisib (GDC-0032) plus fulvestrant in patients (pts) with oestrogen receptor (ER)-positive, HER2-negative locally advanced or metastatic breast cancer (BC) enriched for pts with PIK3CA-mutant tumours
J. Baselga et al.
ANNALS OF ONCOLOGY (2016)
FOXA1 Directs H3K4 Monomethylation at Enhancers via Recruitment of the Methyltransferase MLL3
Kamila M. Jozwik et al.
CELL REPORTS (2016)
PI3K/AKT Signaling Regulates H3K4 Methylation in Breast Cancer
Jennifer M. Spangle et al.
CELL REPORTS (2016)
Measurement of PIP3 Levels Reveals an Unexpected Role for p110β in Early Adaptive Responses to p110α-Specific Inhibitors in Luminal Breast Cancer
Carlotta Costa et al.
CANCER CELL (2015)
Phase I study of the PI3Kα inhibitor BYL719 plus fulvestrant in patients with PIK3CA-altered and wild type ER+/HER2-locally advanced or metastatic breast cancer
Filip Janku et al.
CANCER RESEARCH (2015)
Phase I study of PI3Kα inhibitor BYL719+aromatase inhibitor (AI) in patients (pts) with hormone receptor-positive (HR plus ) metastatic breast cancer (MBC)
Payal D. Shah et al.
CANCER RESEARCH (2015)
Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer
Giovanni Ciriello et al.
CELL (2015)
Disruption of KMT2D perturbs germinal center B cell development and promotes lymphomagenesis
Jiyuan Zhang et al.
NATURE MEDICINE (2015)
PI3K inhibition results in enhanced estrogen receptor function and dependence in hormone receptor-positive breast cancer
Ana Bosch et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Convergent loss of PTEN leads to clinical resistance to a PI(3)Kα inhibitor
Dejan Juric et al.
NATURE (2015)
Trimmomatic: a flexible trimmer for Illumina sequence data
Anthony M. Bolger et al.
BIOINFORMATICS (2014)
Characterization of the Novel and Specific PI3Kα Inhibitor NVP-BYL719 and Development of the Patient Stratification Strategy for Clinical Trials
Christine Fritsch et al.
MOLECULAR CANCER THERAPEUTICS (2014)
deepTools: a flexible platform for exploring deep-sequencing data
Fidel Ramirez et al.
NUCLEIC ACIDS RESEARCH (2014)
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin et al.
BIOINFORMATICS (2013)
GDC-0032, a beta isoform-sparing PI3K inhibitor: Results of a first-in-human phase la dose escalation study.
Dejan Juric et al.
CANCER RESEARCH (2013)
Ph1b study of the PI3K inhibitor GDC-0032 in combination with fulvestrant in patients with hormone receptor-positive advanced breast cancer
D. Juric et al.
CANCER RESEARCH (2013)
The MLL3/MLL4 Branches of the COMPASS Family Function as Major Histone H3K4 Monomethylases at Enhancers
Deqing Hu et al.
MOLECULAR AND CELLULAR BIOLOGY (2013)
Targeted disruption of the EZH2-EED complex inhibits EZH2-dependent cancer
Woojin Kim et al.
NATURE CHEMICAL BIOLOGY (2013)
Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position
Jason D. Buenrostro et al.
NATURE METHODS (2013)
The COMPASS Family of Histone H3K4 Methylases: Mechanisms of Regulation in Development and Disease Pathogenesis
Ali Shilatifard
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 81 (2012)
The Histone Demethylase KDM1A Sustains the Oncogenic Potential of MLL-AF9 Leukemia Stem Cells
William J. Harris et al.
CANCER CELL (2012)
Enhancer-associated H3K4 monomethylation by Trithorax-related, the Drosophila homolog of mammalian Mll3/Mll4
Hans-Martin Herz et al.
GENES & DEVELOPMENT (2012)
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
Michael T. McCabe et al.
NATURE (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
FUNCTIONAL GENOMICS Complexities of occupancy and sequence
Mary Muers
NATURE REVIEWS GENETICS (2012)
MEASURING REPRODUCIBILITY OF HIGH-THROUGHPUT EXPERIMENTS
Qunhua Li et al.
ANNALS OF APPLIED STATISTICS (2011)
DOT1L, the H3K79 methyltransferase, is required for MLL-AF9-mediated leukemogenesis
Anh Tram Nguyen et al.
BLOOD (2011)
FOXA1 is a key determinant of estrogen receptor function and endocrine response
Antoni Hurtado et al.
NATURE GENETICS (2011)
PBX1 Genomic Pioneer Function Drives ERα Signaling Underlying Progression in Breast Cancer
Luca Magnani et al.
PLOS GENETICS (2011)
edgeR: a Bioconductor package for differential expression analysis of digital gene expression data
Mark D. Robinson et al.
BIOINFORMATICS (2010)
ChIPpeakAnno: a Bioconductor package to annotate ChIP-seq and ChIP-chip data
Lihua J. Zhu et al.
BMC BIOINFORMATICS (2010)
Simple Combinations of Lineage-Determining Transcription Factors Prime cis-Regulatory Elements Required for Macrophage and B Cell Identities
Sven Heinz et al.
MOLECULAR CELL (2010)
The nuts and bolts of AGC protein kinases
Laura R. Pearce et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
Cell-type selective chromatin remodeling defines the active subset of FOXA1-bound enhancers
Jerrome Eeckhoute et al.
GENOME RESEARCH (2009)
Ultrafast and memory-efficient alignment of short DNA sequences to the human genome
Ben Langmead et al.
GENOME BIOLOGY (2009)
FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription
Mathieu Lupien et al.
CELL (2008)
Model-based Analysis of ChIP-Seq (MACS)
Yong Zhang et al.
GENOME BIOLOGY (2008)
Opinion - Oestrogen-receptor-mediated transcription and the influence of co-factors and chromatin state
Kelly A. Green et al.
NATURE REVIEWS CANCER (2007)
Identification of the MLL2 complex as a coactivator for estrogen receptor α
Rigen Mo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Akt-mediated phsophorylationof EZH2 suppresses methylation of lysine 27 in histone H3
TL Cha et al.
SCIENCE (2005)
Bioconductor: open software development for computational biology and bioinformatics
RC Gentleman et al.
GENOME BIOLOGY (2004)
分享论文
